2-({[2-(2-chlorophenyl)-7-oxo-6,7-dihydropyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanyl}methyl)-6,7,8,9-tetrahydro-4H-pyrimido[2,1-b][1,3]benzothiazol-4-one
Chemical Structure Depiction of
2-({[2-(2-chlorophenyl)-7-oxo-6,7-dihydropyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanyl}methyl)-6,7,8,9-tetrahydro-4H-pyrimido[2,1-b][1,3]benzothiazol-4-one
2-({[2-(2-chlorophenyl)-7-oxo-6,7-dihydropyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanyl}methyl)-6,7,8,9-tetrahydro-4H-pyrimido[2,1-b][1,3]benzothiazol-4-one
Compound characteristics
Compound ID: | G199-0510 |
Compound Name: | 2-({[2-(2-chlorophenyl)-7-oxo-6,7-dihydropyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanyl}methyl)-6,7,8,9-tetrahydro-4H-pyrimido[2,1-b][1,3]benzothiazol-4-one |
Molecular Weight: | 497 |
Molecular Formula: | C22 H17 Cl N6 O2 S2 |
Smiles: | C1CCC2=C(C1)N1C(=NC(CSC3=NC(c4ccccc4[Cl])=NC4=CC(NN34)=O)=CC1=O)S2 |
Stereo: | ACHIRAL |
logP: | 3.1024 |
logD: | 3.1024 |
logSw: | -3.7835 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 76.069 |
InChI Key: | KXZYDWTZUHTJOG-UHFFFAOYSA-N |